Light‐intensity and moderate‐to‐vigorous intensity physical activity among older adult breast cancer survivors with obesity: A narrative review
Open Access
- 26 May 2022
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 11 (23) , 4602-4611
Abstract
Background: With an aging population, rising incidence of breast cancer, improved survival rates, and obesity epidemic, there will be a growing population of older adult breast cancer survivors with obesity. This complex population, often with multimorbidity, is at risk for several poor health outcomes, including recurrence, cardiovascular disease, dementia, and diabetes, and a number of deleterious symptoms, including a worsened inflammatory profile, breast cancer‐ related lymphedema, mobility disability, cognitive impairment, anxiety, and depressive symptoms. A wealth of meta‐analytic and randomized controlled trial evidence show that adherence to World Health Organization and 2018 United States Physical Activity guidelines‐based levels of moderate‐to‐vigorous physical activity (MVPA) reduces risk of all‐cause mortality, and improves symptoms. However, few survivors engage in recommended levels of MVPA, and symptoms related to their multimorbidity may preclude engaging in sufficient levels of MVPA. Additional research of MVPA in this population is warranted; however, understudied light‐intensity physical activity (LIPA) may be a more pragmatic target than MVPA among this complex population facing extensive challenges meeting MVPA recommendations. Large benefits are likely to occur from increasing these survivors' total activity, and LIPA prescriptions may be a more pragmatic approach than MVPA to aid this transition.Methods: We present a broad, narrative review of the evidence for MVPA and LIPA in this population on an array of health outcomes across the translational science spectrum (clinical, implementation, and public health), and identify a number of directions for future research focused on understanding the potential diverse health effects of LIPA.Conclusion: Additional LIPA research is warranted, as LIPA prescriptions may be a pragmatic strategy to effectively promote physical activity to this complex population.Keywords
Funding Information
- American Cancer Society (MSRG/18‐136‐01‐CPPB)
- Four Diamonds
- National Cancer Institute (F32/CA247263, K07/CA215937)
- National Institute on Aging (R00/AG056670)
This publication has 60 references indexed in Scilit:
- Age As a Risk FactorMedical Clinics of North America, 2012
- Feasibility of Reducing Older Adults' Sedentary TimeAmerican Journal of Preventive Medicine, 2011
- Barriers to physical activity in older adults in Germany: a cross-sectional studyInternational Journal of Behavioral Nutrition and Physical Activity, 2011
- Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?Breast Cancer Research and Treatment, 2010
- Balancing Lymphedema RiskExercise and Sport Sciences Reviews, 2010
- Older Breast Cancer Survivors' Views and Preferences for Physical ActivityQualitative Health Research, 2009
- Cancer-related inflammationNature, 2008
- Epidemiology and risk factors of dementiaJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Cognitive impairment associated with adjuvant therapy in breast cancerPsycho-Oncology, 2005
- Weight, Weight Gain, and Survival After Breast Cancer DiagnosisJournal of Clinical Oncology, 2005